CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 19 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03406325
NCT03406325N/ACompleted

Assessment of Mast Cell Activation Diagnostic Test in Patients With Allergic Disease

Hong Kong Sanatorium & Hospital·observational·Posted Jan 23, 2018·Updated Apr 9, 2020

In Brief

An observational study for Asthma and 6 related conditions. Completed, enrolled 19 participants across 1 site.

Detailed Summary

Activation of mast cells in the immune system is known to cause allergic reactions sometimes with severe systemic symptoms. The investigators have recently developed a blood-based mast cell activation diagnostic test in which levels of functional activation in-vitro in primary cultured mast cells generated from the peripheral blood of single individuals can be assessed. It is the hypothesis that the test can be used to predict the potential state of in-vivo mast cell activation in any individual based on the functional activation profiles exhibited by their cultured mast cells. The investigators now wish to translate their in-vitro findings in a pilot study to disease groups where mast cell activation is expected to be high. These include highly allergic individuals; those with chronic idiopathic urticaria; those with mastocytosis; and those with the mast cell activation syndrome. Furthermore, they will use the functional genomics approach to identify gene expression biomarkers that are correlated with such diseases. The results will be compared with data that have been collected from a cohort of healthy control blood donors.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesHong Kong

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJan 23, 2018
Enrollment StartFeb 1, 2018
Primary CompletionDec 1, 2019
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 8.4 years ago